By silencing the genes that cause harm, we aim to preserve minds, protect memories, and enable our loved ones to live healthier, longer lives.
Browser storage is unavailable. Keep this page open and export your collection before leaving.
Biotech pharma
Aerska
Overview
Developing RNA medicines to treat, delay, and prevent diseases of the brain.
Company description As recorded 2026-09-20
Product & workflow
Source-reported As recorded 2026-09-23
News & product activity
Cohort membership
Entrepreneur First 20252025
Original evidence ↗Sources & observations
Entrepreneur First · Speedinvest
Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedExternal
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 2 of 6 areas documented
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.
- Product overviewSource description Checked 2026-09-20
- Product visualsNot documented
- Founders & originsNot documented
- Business model & pricingNot documented
- Funding & ownershipNot documented
- Dated milestonesDated source activity: 2025 (year only)
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and model





